Association between ischemic heart disease and systemic lupus erythematosus-a large case-control study (Q39017583)

8 September 2017

Association between ischemic heart disease and systemic lupus erythematosus-a large case-control study (English)

1 reference

systemic lupus erythematosus

8 September 2017

1 reference

0 references

coronary artery disease

1 reference

7

Howard Amital

1 reference

8 September 2017

1

Abdulla Watad

1 reference

8 September 2017

Arsalan Abu Much

2

1 reference

8 September 2017

Danielle Bracco

3

1 reference

8 September 2017

Naim Mahroum

4

1 reference

8 September 2017

Doron Comaneshter

5

1 reference

8 September 2017

Arnon D Cohen

6

1 reference

8 September 2017

17 January 2017

1 reference

8 September 2017

1 reference

8 September 2017

65

1 reference

8 September 2017

2

1 reference

8 September 2017

459-463

1 reference

https://scigraph.springernature.com/pub.10.1007/s12026-016-8884-9

8 September 2017

0 references

cites work

Systemic lupus erythematosus risk factors for coronary artery calcifications.

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Bipolar disorder associated with rheumatoid arthritis: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Coexistence of ischemic heart disease and rheumatoid arthritis patients-A case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Hyperthyroidism association with SLE, lessons from real-life data--A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

The bimodal mortality pattern of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Systemic lupus erythematosus and atherosclerosis: Review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Apolipoprotein-containing lipoprotein subclasses and subclinical atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Risk factors in the progression of subclinical atherosclerosis in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Risk factors for cardiovascular disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Cardiovascular disease in autoimmune rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Control of autoimmune diseases by the vitamin D endocrine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Contribution of vitamin D deficiency to the risk of coronary heart disease in subjects with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Vitamin D plasma levels and in-hospital and 1-year outcomes in acute coronary syndromes: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-016-8884-9

Risk factors for coronary artery disease in patients with systemic lupus erythematosus

21 January 2018

1 reference

12 December 2020

Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease

1 reference

12 December 2020

25-Hydroxy-vitamin D level may predict presence of coronary collaterals in patients with chronic coronary total occlusion

1 reference

12 December 2020

Lipid profile among girls with systemic lupus erythematosus

1 reference

12 December 2020

Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus

1 reference

12 December 2020

Lupus Atherosclerosis Prevention Study (LAPS)

1 reference

12 December 2020

The increased risk of coronary heart disease associated with nephrotic syndrome

1 reference

12 December 2020

Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus

1 reference

12 December 2020

Does Renin-Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case-Control Study

1 reference

12 December 2020

Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study

1 reference

12 December 2020

Coeliac disease associated with psoriasis

1 reference

12 December 2020

Accelerated atherosclerosis in systemic lupus erythematosus: implications for patient management

1 reference

12 December 2020

Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome

1 reference

12 December 2020

Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices

1 reference

12 December 2020

Hydrocortisone directly promotes cholesterol accumulation in macrophages

1 reference

12 December 2020

Duplex study of the carotid and femoral arteries of patients with systemic lupus erythematosus: a controlled study.

1 reference

12 December 2020

Relationship between homocysteine levels and hypertension in systemic lupus erythematosus

1 reference

12 December 2020

10.1007/S12026-016-8884-9

Identifiers

DOI

1 reference

8 September 2017

1 reference